Trial Profile
A Randomized Double Blind Parallel-Group Comparative Phase 1/2 Study to Evaluate the Safety and Immunogenicity of a Single Subcutaneous Injection of TAK-850 in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Jan 2022
Price :
$35
*